Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anavex Life Sciences starts AD drug dosing in Phase I clinical trial
ANAVEX 2-73 is the first of a new class of oral, disease-modifying drugs being studied to potentially treat AD itself, versus treating its symptoms. The Phase I clinical
ANAVEX 2-73 is the first of a new class of oral, disease-modifying drugs being studied to potentially treat AD itself, versus treating its symptoms. The Phase I clinical
The execution of the trial entitles Dynavax to receive a $6m milestone payment from GSK, its partner in a worldwide strategic alliance. As per the terms of the
The study results showed increase in lumbar spine bone mineral density at month 12 for the AMG 785/CDP7851 active arms versus the placebo arm. The study was planned
Elan’s net income was $68.2m, or $0.12 per diluted share, compared to a net loss of $6.8m, or $0.01 per diluted share, for the same period in 2010.
The new EMR suite will ease challenges and will offer safe, secure and user- friendly access for patients, according to the company. Keeping patient’s records in a single
Colesevelam HCI 625mg tablets are generic version of Daiichi Sankyo’s Welchol. Welchol is a bile acid sequestrant. It works to decrease cholesterol by increasing the removal of bile
MicroDose intends to submit the investigational new drug (IND) reactivation with the US Food and Drug Administration and to begin MDT-637Phase I study this year. As per the
According to Mylan, Famciclovir tablets, 125mg, 250mg are the generic version version of Novartis’ Famvir tablets. Novartis‘ Famvir (famciclovir) is a prescription oral antiviral drug which is indicated
The company’s novel approach uses stem cells harvested from the patient’s bone marrow into which a healthy version of the disease causing gene is inserted. After being grown
Hebei Aoxing API Pharmaceutical is a joint venture (JV) between Hebei Aoxing Pharmaceutical Group, a subsidiary of Aoxing Pharma and Macfarlan Smith, a subsidiary of Johnson Matthey. Naloxone